In human laryngeal carcinoma, tissue down-regulation of NLK inhibited tumour cell proliferation and invasion, suggesting that NLK might be used as a potential molecular target for development and diagnosis of laryngeal carcinoma [31]. Here, NLK is linked to laryngeal carcinoma.